SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-009485
Filing Date
2014-02-14
Accepted
2014-02-14 14:19:10
Documents
1
Group Members
KLEINER PERKINS CAUFIELD & BYERS IX-A, L.P.KLEINER PERKINS CAUFIELD & BYERS IX-B, L.P.KLEINER PERKINS CAUFIELD & BYERS X-B, L.P.KPCB IX ASSOCIATES, LLCKPCB X ASSOCIATES, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G v368413_sc13g.htm SC 13G 97988
  Complete submission text file 0001144204-14-009485.txt   99547
Mailing Address
Business Address 2750 SAND HILL RD MENLO PARK CA 94025
KLEINER PERKINS CAUFIELD & BYERS X A LP (Filed by) CIK: 0001118829 (see all company filings)

IRS No.: 943365493 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87623 | Film No.: 14614682
SIC: 2834 Pharmaceutical Preparations